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Abstract
This study determined if the co-ingestion of carbohydrate (CHO) with branched-chain amino acids
(BCAA) or L-leucine (LEU) preferentially affected serum IGF-1 and the expression of myogenic-related genes in
response to resistance exercise (RE). Forty one, college-age males were randomly assigned to 1 of 4 groups: CHO,
CHO-BCAA, CHO-LEU, or placebo (PLC). Resistance exercise consisted of 4 sets of leg press and leg extension at
80% 1RM. Supplements were ingested peri-exercise, and venous blood and muscle biopsies were obtained preexercise (PRE), and at 30, 120, and 360 min post-exercise. Serum IGF-1 was determined with ELISA, and skeletal
muscle mRNA expression of myostatin, ActRIIB, p21kip, p27kip, CDK2, cyclin B1, cyclin D1, Myo-D, myogenin,
MRF-4, and myf5 was determined using real-time PCR. Results were determined with two-way ANOVA for serum
IGF-1 and two-way MANOVA for mRNA expression. Serum IGF-1 in CHO and CHO+BCAA was greater than
PLC (p < 0.05) but was not affected by RE (p > 0.05). Significant differences were detected between groups for myostatin, ActIIB, MyoD, and myf5 mRNA expression showing CHO to be significantly different than CHO+BCAA,
CHO+LEU, and PLC (p < 0.05). At 30, 120 and 360 min post-exercise, p21cip was significantly less than PRE,
whereas cyclin D1 was greater than PRE at 120 and 360 min post-exercise (p < 0.05). The co-ingestion of CHO with
either BCAA or L-leucine in conjunction with RE had no preferential effect on serum IGF-1 or pre-translational
markers indicative of myogenesis.
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INTRODUCTION
Skeletal muscle exhibits inherent plasticity in its
ability to adapt to various mechanical, hormonal,
and nutritional stimuli by possessing the capability to alter its phenotype. Moreover, the ability of
skeletal muscle to undergo hypertrophic changes
in respone to resistance exercise is under the control of anabolic and catabolic signaling pathways
that operate at both the pre- and posttranslational levels to help maintain the balance
between protein synthesis and proteolysis. Two
primary cellular processes are involved with hypertrophy responses in mammalian skeletal mus2	
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cle. The first process involves both pre- and posttranslational mechanisms that result in the accretion of myofibrillar protein and subsequent myofiber enlargement due to increases in the myonuclear domain (Bickel et al. 2005; Shelmadine et
al. 2009). The second process results in myofiber
enlargenment due to a decreased myonuclear
domain resulting from activation and proliferation of myogenic satellite cells which fuse into
muscle fibers, thereby providing additional myonuclei for augmented transcriptional activity and
subsequent protein synthesis (Han et al. 2008).
Muscle damage that occurs in response to resistance exercise from both dynamic/isotonic
(Willoughby & Nelson, 2002; Psilander et al.
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2003) and forced-lengthening (eccentric) muscle
contractions (Farup et al. 2014) have been shown
to effectively increase markers of satellite cells
activity and/or the number of activated satellite
cells.
Muscle protein accretion, mediated by satellite cell activation, is modulated by the motiotic
and myogenic activity of insulin-like growth factor 1 (IGF-1), which functions in an endocrine/autocrine/paracrine mode and functions
through the binding to the IGF-1 receptor (IGF1R). This ligand-receptor interaction triggers intracellular signaling cascades through extracellular-regulated kinase (ERK) and protein kinase B
(Akt) which play a role in the proliferation and
differentiation, respectively, of satellite cells
(Philippou et al. 2007). Upon activation, however,
the process of myogenesis is controlled by several myogenic regulatory factors (MRFs) which
serve as transcription factors and act as terminal
effectors of the signaling cascades and produce
appropriate stage-specific transcripts. The expansion of activated satellite cells occurs from myogenic factor 5 (myf5). Myoblast determination
protein (Myo-D) is involved in determining the
differentiation poteintial of an activated myoblast
and acts together with myogenin to drive differentiation, whereas muscle-specific regulatory
factor 4 (MRF-4) is required for hypertrophy as
it plays a role in the maturation of myotubes
(Knight & Kothary, 2011).
Along with the MRFs, the myogenic activation of satellite cells is also regulated by cyclindependent kinases (CDKs) which have a catalytic dependence on the cyclin family of regulatory
proteins. Cyclin D, a G1 cyclin which regulates
progression through G1 and entry into the S
phase of the cell cycle, is responsible for its role
in myoblast differentiation by activating CDK2
(Knight & Kothary, 2011). For myoblasts to differentiate, the cell cyle must be exited and the
restraints the CDKs place on differentitation
must be removed. As such, the expression of cyclin D1, cyclin B1, and CDK2 decreases with
differentiation (Jahn et al. 1994; Skapek et al.
1995).
Concomitant with the decreased expression
of cyclin/CDKs, there is an increase in the levels
3	
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of the cyclin-dependent kinase-interacting protein/kinase-inhibitory protein family (CIP/KIP).
The CIP/KIPs, p21cip and p27kip, inhibit all G1
CDKs (Knight & Kothary, 2011). Furthermore,
myostatin which is a member of the transforming
growth factor beta (TGF-β) family works in a
paracrine/autocrine manner through the activin
IIB receptor (ACTRIIB), and is a negative regulator of myogenesis and subsequent muscle protein accretion by repressing the expression of
Myo-D, myogenin, myf5, and p21cip, and by
down-regulating cyclin D1 during the G1 phase
of the cell cycle (Langley et al. 2002).
Nutrients, amino acids in particular, play an
important role in regulating muscle protein accretion. Moreover, delivery and uptake of carbohydrate (CHO) and protein may influence satellite cell activity, as it has recently been shown
that both nutrients increased the number of satellite cells per myonuclei during recovery following eccentric exercise (Farup et al. 2014). The
mechanism(s) in which nutrient availability may
increase myogenic activity is not well known but
may be associated with the process in which
CHO and branched-chain amino acids (BCAAs)
contained in protein are able to increase muscle
protein synthesis (Miller et al. 2003) and upregulate intramuscular signaling cascades known
to effect myogenic regulators such as ERK (Di
Camillo et al. 2014) and Akt (Ferreira et al.
2014). Relative to the role that nutrient availability plays in inducing muscle hypertrophy, it has
been shown that the immediate ingestion of either CHO and/or amino acids after resistance exercise results in an increase in skeletal muscle
protein synthesis (Biolo et al. 1997; Miller et al.
2003). The branched-chain amino acids
(BCAAs), in particular leucine, simulate protein
synthesis through signalling pathways involving
mTOR (mammalian target of rapamycin) (Kimball & Jefferson, 2006; Rennie, 2007) in a doseresponse manner and seems independent of serum insulin and IGF-1. Furthermore, we have
previously shown that the insulinogenic response
from the co-ingestion of CHO and BCAA instigated no related response to RE in mediating increases in the activity of Akt, mTOR, and
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P70S6K, signaling markers indicative of muscle
protein synthesis (Ferreira et al. 2014).
However, currently there appear to be no
published data available to elucidate the effects
that CHO and BCAAs may have on the gene expression of myogenic markers on satellite cell
activation in response to resistance exercise in
humans. Therefore, the purpose of the study was
to determine the effects of the co-ingestion of
CHO with either BCAA or LEU in response to a
single bout of heavy exercise on serum IGF-1
and the skeletal muscle expression of the myogenically-related genes, myostatin, ActRIIB,
p21cip, p27kip, CDK2, cyclin B1, cyclin D1,
MyoD, myogenin, MRF-4, and myf5.
METHODS
Experimental Design
The study involved a fully-randomized, fourgroup, factorial, repeated-measures design in
which each group received a separate periexercise nutritional supplement while performing
an identical bout of resistance exercise. Blood
and muscle samples were obtained immediately
before and 30, 120, and 360 min following exercise. These data presented herein are a subset
from our previous study in which a more comprehensive discussion of the methods, illustration
of study timeline, and various data, such as serum insulin and dietary intake, is presented elsewhere (Ferreira et al. 2014).
Participants
A total of 46 individuals were screened for eligibility in the study. Five individuals were not included in the study for the following reasons:
two did not meet inclusion criteria, one chose not
to participate due to the muscle biopsies, and two
chose not to participant due to time constraints.
Therefore, 41 physically-active, apparentlyhealthy men between the ages of 18-30 years
served as participants in the study. While the
men were physically active (engaging in nonstructured activity of a physical nature), they
were not resistance-trained. Participants were
excluded if they had been performing a struc4	
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tured resistance training program more than
thrice weekly in the previous year and/or who
had performed lower-body resistance exercise in
the 14 days immediately prior to the study. Only
participants considered as either low or moderate
risk for cardiovascular disease and with no contraindications to exercise as outlined by the
American College of Sports Medicine (Whaley,
2005) and/or who had not consumed any nutritional supplements (excluding multi-vitamins
and protein supplements) one month prior to the
study were allowed to participate. All 41 participants who began were able to successfully completed the study without any complications.
Familiarization Session, Baseline Strength
Testing, and Randomization to Groups
During the familiarization session, participants
received both written and verbal description of
the study design and requirements and read and
signed university-approved documents granted
by the Institutional Review Board for Human
Subjects of Baylor University. Height and body
mass measures were obtained, then participants
had their one repetition maximum (1-RM) determined on the angled leg press (Nebula Fitness,
Inc., Versailles, OH) and knee extension (Body
Masters, Inc., Rayne, LA) exercises as previously described (Ferreira et al. 2014). After baseline
strength testing, each subject was matched according to muscle strength and body mass and
then randomly assigned to one of four supplement groups [CHO (n = 10), CHO + BCAA
(n = 10), CHO + LEU (n = 11), placebo (n = 10)].
Resistance Exercise Session Protocol
Participants arrived at the lab in the morning between 8-10 am following an overnight fast, adequately hydrated, and rested (no lower-body exercise for 72 hours prior to baseline testing). Participants brought a completed 48-hr food record
to the resistance exercise session. Participants
performed four sets each of the angled leg press
and knee extension exercises at 80% 1-RM until
failure (approximately 8-12 repetitions). Rest
periods were 2.5 min between both sets and exercises constituted a 1:5 work to rest ratio. The
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exercise session was approximately 30 min in
duration (Ferreira et al. 2014).
Supplementation Protocol
The BCAA supplement (Now Foods, Bloomingdale, IL) was comprised of 50% leucine, 25%
isoleucine, and 25% valine. The orally ingested
dosage of BCAA was 120 mg/kg body mass (60
mg/kg leucine, 30 mg/kg isoleucine, and 30
mg/kg valine per each participant) (Karlsson et al.
2004). The LEU supplement (Source Naturals,
Scotts Valley, CA) was provided at a dosage of
120 mg/kg per each participant. The amount of
maltodextrin in the CHO supplement for each
group was provided at a dosage of 1.5 g/kg body
mass (approximately 120 g per each participant),
which had been shown to induce a significant
insulogenic response (Schumm et al. 2008). The
placebo (PLC) supplement was non-caloric Crystal Light®. Each supplement was ingested in
equal parts dissolved in 150 mL of a flavored
non-caloric beverage (of Crystal Light®), for a
total supplement ingestion of 450mL. Participants ingested the assigned supplement dose at
each of the following time points: 30 min prior to
RE, immediately prior to RE, 5 min following
RE.
Venous Blood Sampling and Muscle Biopsies
Venous blood was collected from the antecubital
vein using a vacutainer apparatus and standard
phlebotomy procedures. Vacutainer tubes were
immediately centrifuged at 1,100 g for 15
minutes (Cole Parmer, Vernon Hills, IL). Serum
was then separated and transferred in sterile
cryo-vials and stored at -80°C for future analyses.
Upon subcutaneous anesthetization with 1%
lidocaine, muscle biopsies (~50-75 mg) were extracted from the left vastus lateralis midway between the patella and the greater trochanter at a
depth of 1-2 cm using the percutaneous biopsy
technique with suction as previously described
(Bergstrom, 1975; Evans et al. 1982; Ferreira et
al., 2014). The same incision location was used
for the subsequent excisions, and sampling depth
was verified by depth markings on the biopsy
needle. Following the initial biopsy, for each
5	
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subsequent biopsy the needle was rotated in the
clock-wise direction from the previous biopsy
(biopsy 1 = 1,200 hours; biopsy 2 = 1,500 hours;
biopsy 3 = 1,800 hours; biopsy 4 = 2,100 hours)
so the sample was taken from within the same
area of muscle. Previous research has shown that
a multiple biopsy technique does not alter exercise-induced gene expression (Lundby et al. 2005;
Willoughby & Nelson, 2002). Collected muscle
tissue samples were placed in sterile cryovials,
flash frozen in liquid nitrogen, and stored at -80º
C for future analysis. Blood and muscle samples
were obtained immediately prior (PRE) to the
first bolus of supplement, and at 30, 120, and 360
min following RE.
Serum IGF-1
Serum IGF-1 was analyzed using a commercially
available ELISA kit (Diagnostic Systems Laboratories Inc. Webster, TX). According to the
manufacturer, the sensitivity for this assay was
0.01ng/mL. A standard curve was generated using a control peptide and absorbances were determined in duplicate at an optical density of 450
nm with a microplate reader (Wallac Victor 1420,
Perkin Boston, MA, USA). IGF-1 concentrations
were quantified using MicroWin microplate datareduction software (Mikrotek Laborysteme,
Germany). The overall intra-assay coefficient of
variation was 7.1%.
Skeletal Muscle Total RNA Isolation and
Quantitation and cDNA Synthesis
Following our previously established procedures
(Wilborn et al. 2009; Willougbhy et al. 2007),
approximately 20 mg of muscle tissue was homogenized in a of monophasic solution of phenol
and guanidine isothiocyanate contained within
the TRI-reagent (Sigma Chemical Co., St. Louis,
MO). Total RNA concentrations were determined spectrophotometerically (Helio γ, Thermo
Electron, Milford, MA) by optical density (OD)
at 260 nm using an OD260 equivalent to 40
μg/μl (Ausubel et al. 2002), and the final concentration expressed relative to muscle wet weight.
Aliquots of total RNA were separated with 1%
agarose gel electrophoresis, ethidium bromide
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stained, and monitored under an ultraviolet light
(Chemi-Doc XRS, Bio-Rad, Hercules, CA) to
verify RNA integrity and absence of RNA degradation, indicated by prominent 28s and 18s ribosomal RNA bands, as well as an
OD260/OD280 ratio of approximately 2.0. Testretest reliability of performing this procedure of
total RNA integrity on samples in our laboratory
has demonstrated low mean coefficients of variation and high reliability (1.8%, intraclass
r = 0.96). The RNA samples were stored at 80°C until later analysis.
Total skeletal muscle RNA was reversetranscribed to synthesize cDNA using the iScript
cDNA Synthesis Kit (Bio-Rad, Hercules, CA,
USA). The cDNA concentration was determined
by using an OD260 equivalent to 50 μg/μl (Ausubel et al. 2002), and the starting cDNA template concentration was standardized by adjusting all samples to 200 ng prior to PCR amplifica-

tion (Wilborn et al. 2009; Willoughby et al.
2007).
Oligonucleotide Primers for PCR
The mRNA sequences of human skeletal muscle
published in the NCBI Entrez Nucleotide database (www.ncdi.nlm.hih.gov) were used to construct oligonucleotide PCR primers with Beacon
Designer software (Bio-Rad, Hercules, CA, USA)
(Table 1). Primer pairs were synthesized commercially (Integrated DNA Technologies, Coralville, IA). β-actin was used as an external control
standard for each reaction due to its consideration as a constitutively expressed "housekeeping
gene," and the fact that it has been shown to be
an appropriate external reference standard in real-time PCR in human skeletal muscle following
acute exercise (Mahoney et al. 2004; Wilborn et
al. 2009; Willoughby et al. 2007).

Table 1. Nucleotide sequences of sense and antisense primers used for real-time PCR.

Primer Name

NCBI Accession
Number

Sense Sequence
(5' → 3')

Anti-Sense Sequence
(5' → 3')

β-Actin

NM_001101

Myostatin

NM_005259

ActRIIB

NM_001106

Cyclin B1

ATCGTGCGT
GACATTAAG
CAAGAAYAGAAG
CCATTAAGATAC
GCCTTGCCAT
CAGATTGTG

GTCATCACC
ATTGGCAAT
CGTTGTAGCG
TGATAATCG
GCCATCAGAAC
CAGATATACC

NM_031966

TGCCTCTCCA
AGCCCAATG

TTCCTCAAGTTGT
CTCAGATAAGC

178

Cyclin D1

NM_001758

CAACTTCCTG
TCCTACTACC

TCCTCCTCC
TCCTCTTCC

177

CDK2

X61622

GCACTACGAC
CCTAACAAG

CCACCTGAGT
CCAAATAGC

190

P21cip

L25610

TCCAGCGACCT
TCCTCATCCAC

TCCATAGCCTCT
ACTGCCACCATC

108

p27kip

NM_004064

CAGGAGAGC
CAGGATGTC

TAGAAGAATC
GTCGGTTGC

175

Myo-D

X56677

CGCCACCGC
CAGGATATG

GTCATAGAAGT
CGTCCGTTGTG

108

Myogenin

X62155

TGAGGAGGTAAC
ATAGAAGGACAG

CAGCAGCCG
TGGTCAGAG

148

MRF-4

NM_002469

ACTGGCTCCTAT
TTCTTCTACTTG

TTCCTCTCC
GCTGCTGTC

159

myf5

X14894

GAGCAGGTG
GAGAACTAC

GTGGCATATACA
TTTGATACATC

170
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Amplicon Size
(bp)
102
194
155
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Real-Time PCR Amplification and Quantitation
Following our previous procedures (Wilborn et
al., 2009; Willoughby et al. 2007), each reaction
was amplified using real-time quantitative PCR
system (iCycler IQ Real-Time PCR Detection
System, Bio-Rad, Hercules, CA, USA). To help
control for differences in amplification efficiency
during thermocycling, all PCR reactions were
prepared from the same stock solution. The specificity of the PCR was demonstrated with an absolute negative control using a separate PCR reaction containing no cDNA and a single gene
product was confirmed for each primer pair using
DNA melt curve analysis. Additionally, to assess
positive amplification of mRNA and correct amplicon size, random aliquots of PCR reaction
mixtures from each sample were agarose gel
electrophoresed stained with ethidium bromide
and ultra-violetly illuminated (Chemi-Doc XRS,
Bio-Rad, Hercules, CA). Based on our previous
work, the relative expression of mRNA was determined as the ratio of the threshold cycle (Ct)
values of each target mRNA to the corresponding
Ct values of β-actin for each muscle sample (Serra et al. 2012; Wilborn et al., 2009; Willoughby
et al. 2007). Test-retest reliability of performing
this procedure of mRNA expression on samples
in our laboratory has demonstrated low mean coefficients of variation and high reliability (1.6%,
intraclass r = 0.95).

committing a Type I error that could result from
the use of repeated univariate ANOVA; in contrast, this would increase the likelihood of performing type II error, particularly with a low
sample size. Separate ANOVAs on each dependent variable were conducted as follow-up tests to
the MANOVA. To control for alpha-level inflation, the Bonferroni test was utilized for multiple
comparisons.
In addition to reporting probability values, an
index of effect size was reported to reflect the
magnitude of the observed effect. The index of
effect size utilized was partial Eta squared (η2),
which estimates the proportion of variance in the
dependent variable that can be explained by the
independent variable. Partial Eta squared effects
sizes were determined to be: weak = 0.17, medium = 0.24, strong = 0.51, very strong => 0.70 as
previously described by (O'Connor et al., 2007).
In addition, for all statistical analyses not meeting the sphericity assumption for the withinsubjects analyses, a Greenhouse-Geisser correction factor was applied to the degrees of freedom
in order to increase the critical F-value to a level
that would prevent the likelihood of committing
a type I error. All statistical procedures were performed using SPSS 21.0 software (Chicago, IL)
and a probability level of <0.05 was adopted
throughout.
RESULTS
Participant Demographics

Statistical Analyses
A one-way analysis of variance (ANOVA) was
calculated on all dependent variables to determine if significant differences existed at baseline
between the four groups. A one-way ANOVA
was performed on exercise volume for the four
groups. A 4 × 4 (group × time point) univariate
ANOVA was performed for serum IGF-1. A 4 ×
4 (group × time point) multivariate ANOVA
(MANOVA) was determined on skeletal muscle
mRNA variables. Due to the likelihood that the
expression of our targeted genes were possibly
being contingent on one another, the use of a
MANOVA analysis prevented the chance of
7	
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Descriptive statistics (means ±SD) for body mass,
age, and height, are reported in Table 2. No significant differences were found to exist at baseline between groups for participant demographics,
serum IGF-1, or any of the mRNA variables assessed (p > 0.05).
Total Lifting Volume and Macronutrient Intake
The mean ±SD exercise volume, expressed as
total lifting volume for both the leg press and leg
extension for the resistance exercise sessions was
16,962 ±7,699 kg, 16,298 ±3,608 kg, 15,692
±4,516 kg, and 17,784 ±6,600 kg for CHO,
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CHO+BCAA, CHO+LEU, and PLC, respectively. Results demonstrated no significant differences in exercise volume (p > 0.05). Data from
nutritional intake is presented elsewhere (Ferreira
et al. 2014), but was not significantly different
between groups (p > 0.05).

0.135). Post-hoc analysis showed that CHO and
CHO+BCAA were significant greater than PLC
(Table 3).
Skeletal Muscle mRNA Expression
For the comprehensive multivariate analysis of
all mRNA variables, Wilks’ Lambda produced a
significant group × time interaction (p = 0.001;
effect size = 1.00). There were also significant
multivariate differences for the main effects for
group (p = 0.001; effect size = 1.00) and time
(p = 0.001; effect size = 1.00).

Serum IGF-1
For serum IGF-1, results revealed no significant
group × time interaction (p = 0.99; effects size =
0.019) or main effect for time (p = 0.97; effect
size = 0.004). However, a significant main effect
for group was found (p = 0.001; effect size =
Table 2. Participant Demographics.
Demographics
Height (cm)
Body Mass (kg)
Age (yrs)

CHO
183.3 ±6.5
81.4 ±14.0
20.4 ±2.5

CHO+BCAA
178.0 ±5.4
77.3 ±15.3
21.8 ±2.6

CHO+LEU
178.1 ±8.4
81.8 ±16.9
20.7 ±3.2

PLC
178.1 ±9.0
83.0 ±11.2
21.0 ±2.4

p ≤ 0.05
0.32
0.83
0.69

Data are reported as means ±SD. No significant differences were found between groups at baseline relative to participant demographics (p > 0.05).

Table 3. Serum IGF-1 Levels for the CHO, CHO+BCAA, CHO+LEU, and PLC Groups.
Variable

Pre

30 Min Post-Ex

120 Min Post-Ex

360 Min Post-Ex

337.35 ±112.49
345.89 ±91.70
302.95 ±115.37
257.61 ±69.90

305.01 ±90.09
397.41 ±141.34
303.05 ±92.27
275.62 ±88.85

327.78 ±87.03
360.82 ±81.07
275.09 ±72.79
267.68 ±87.28

338.49 ±91.42
349.52 ±89.33
270.01 ±67.59
267.16 ±84.92

IGF-1 (ng/ml)
CHO
CHO+BCAA
CHO+LEU
PLC

G

T

G×T

0.001*

0.97

0.99

> PLC
> PLC

Data are presented as means ±SD for the serum values of IGF-1. G, T, and GxT represent the univariate main effects for group, time, and group x time interaction, respectively, at a probability level of ≤ 0.05. The symbol * denotes a significant difference for the group main effect. CHO and CHO+BCAA were
significantly greater than PLC.

mRNA Expression for Markers of Myogenic
Activation
Upon further analysis with univariate ANOVA, a
significant group × time interaction was observed
for cyclin D1 (p = 0.001; effect size = 1.00).
Post-hoc analysis showed that PLC was significantly greater than CHO, CHO+BCAA, and
CHO+LEU at 30, 120, and 360 min post-exercise.
Significant group main effects were observed for
CDK2 (p = 0.002, effect size = 0.92), MyoD
(p = 0.006; effect size = 0.86), and myf5
(p = 0.007; effect size 0.85). For cyclin B1, a
strong trend towards significance was observed
base on a p-value of 0.06 and an effect size of
8	
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0.60. Post-hoc analysis showed that for CDK2,
CHO+BCAA, CHO+LEU, and PLC were significantly greater than CHO. In regard to Myo-D,
CHO, CHO+LEU, and PLC were greater than
CHO+BCAA. For myf5, CHO and CHO+BCAA
were significantly greater than PLC and
CHO+LEU.
Analysis of the time main effects also produced significant differences between time points
for cyclin B1 (p = 0.001; effect size = 0.986).
Post-hoc analysis revealed that PRE was significantly less than 30 and 120 min post-exercise.
For MRF-4, a strong trend towards significance
was observed base on a p-value of 0.07 and an
effect size of 0.58. (Table 4).
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Table 4. mRNA Expression for Markers of Myogenic Activation for the CHO, CHO+BCAA, CHO+LEU, and PLC Groups.
Variable
CDK2
CHO
CHO+BCAA
CHO+LEU
PLC

Pre
0.98 ±0.04
1.06 ±0.05
1.04 ±0.06
1.05 ±0.08

Cyclin B1
CHO
CHO+BCAA
CHO+LEU
PLC

1.04 ±0.02
1.03 ±0.02
1.04 ±0.05
1.02 ±0.05

30 Min
Post-Ex

120 Min
Post-Ex

360 Min
Post-Ex

1.01 ±0.04
1.05 ±0.06
1.02 ±0.07
1.02 ±0.06

1.01 ±0.03
1.03 ±0.07
1.01 ±0.06
1.05 ±0.04

0.99 ±0.05
1.04 ±0.04
1.05 ±0.06
1.03 ±0.07

> PRE

> PRE

1.01 ±0.03
1.02 ±0.01
1.01 ±0.02
1.01 ±0.01

1.02 ±0.01
1.07 ±0.06
1.04 ±0.03
1.05 ±0.02

1.02 ±0.02
1.04 ±0.04
1.05 ±0.04
1.02 ±0.03
> PRE, 30 MIN
POST-EX
1.04 ±0.02
1.00 ±0.01
1.03 ±0.03
1.06 ±0.04

CHO
CHO+BCAA
CHO+LEU
PLC

0.93 ±0.04
1.00 ±0.04
0.98 ±0.03
0.99 ±0.03

0.99 ±0.03
0.98 ±0.02
0.95 ±0.02
1.01 ±0.03

> PRE, 30 MIN
POST-EX
0.98 ±0.02
1.01 ±0.03
1.01 ±0.01
1.04 ±0.02

Myo-D
CHO
CHO+BCAA
CHO+LEU
PLC

1.07 ±0.09
1.00 ±0.05
1.04 ±0.07
1.07 ±0.06

1.04 ±0.07
1.02 ±0.09
1.04 ±0.12
1.02 ±0.09

1.05 ±0.08
0.97 ±0.07
1.07 ±0.07
1.02 ±0.06

1.05 ±0.07
0.99 ±0.06
1.03 ±0.08
1.01 ±0.05

Myogenin
CHO
CHO+BCAA
CHO+LEU
PLC

1.12 ±0.10
1.08 ±0.09
1.05 ±0.04
1.21 ±0.06

1.11 ±0.06
1.08 ±0.10
1.13 ±0.11
1.14 ±0.07

1.09 ±0.10
1.09 ±0.12
1.10 ±0.07
1.06 ±0.08

1.11 ±0.11
1.07 ±0.10
1.06 ±0.11
1.10 ±0.04

MRF-4
CHO
CHO+BCAA
CHO+LEU
PLC

1.20 ±0.15
1.20 ±0.12
1.28 ±0.10
1.03 ±0.10

1.19 ±0.15
1.18 ±0.11
1.24 ±0.19
1.31 ±0.12

1.19 ±0.18
1.20 ±0.14
1.27 ±0.15
1.23 ±0.13

1.20 ±0.17
1.16 ±0.12
1.19 ±0.12
1.12 ±0.12

Myf5
CHO
CHO+BCAA
CHO+LEU
PLC

1.06 ±0.09
1.01 ±0.05
1.08 ±0.05
1.09 ±0.05

1.02 ±0.07
1.03 ±0.07
1.06 ±0.07
1.07 ±0.06

1.02 ±0.08
1.04 ±0.09
1.07 ±0.05
1.04 ±0.03

1.02 ±0.09
1.00 ±0.06
1.01 ±0.07
1.09 ±0.06

Cyclin D1

G

T

G×T

0.002 *

0.88

0.76

0.06

0.001
†

0.13

0.001 *

0.001
†

0.001 ‡

0.52

0.79

0.34

0.58

0.54

0.13

0.07

0.62

0.007 *
> PLC, CHO+LEU
> PLC, CHO+LEU

0.26

0.30

> CHO
> CHO
> CHO

< PLC
< PLC
< PLC
0.006 *
> CHO+BCAA
> CHO+BCAA
> CHO+BCAA

Data are presented as means ±SD for the ratio of Ct values for β-actin and each target mRNA variable. G, T, and G×T represent the univariate main effects
for group, time, and group × time interaction, respectively, at a probability level of ≤ 0.05. The symbol * denotes a significant main effect for group. For
CDK2, CHO+BCAA, CHO+LEU, and PLC were significantly greater than CHO. For cyclin D1, PLC was significantly different from CHO, CHO+BCAA,
and CHO+LEU. For MyoD, CHO+BCAA was significant different than CHO, CHO+LEU, and PLC. For myf5 CHO and CHO+BCAA were significantly
different from PLC, and CHO+LEU was significantly different from CHO+BCAA. The symbol † denotes a significant main effect for test. For cyclin B1,
PRE was significantly less than 30, 120, and 360 min post-exercise. The symbol ‡ denotes a significant group x time interaction. PLC was greater than
CHO, CHO+BCAA, and CHO+LEU at 120 and 360 min post-exercise.
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Table 5. mRNA Expression Data for Markers of Myogenic Inhibition for the CHO, CHO+BCAA, CHO+LEU, and PLC
Groups.
Pre

30 Min
Post-Ex

120 Min
Post-Ex

360 Min
Post-Ex

Myostatin
CHO
CHO+BCAA
CHO+LEU
PLC

1.04 ±0.11
1.07 ±0.09
0.88 ±0.07
0.84 ±0.06

1.00 ±0.10
1.06 ±0.10
0.92 ±0.08
0.89 ±0.05

0.98 ±0.09
1.04 ±0.07
0.93 ±0.07
0.95 ±0.06

0.99 ±0.07
1.05 ±0.06
0.95 ±0.06
0.98 ±0.04

ACTRIIB
CHO
CHO+BCAA
CHO+LEU
PLC

1.06 ± 0.06
0.97 ±0.05
0.91 ±0.03
1.01 ±0.06

1.06 ±0.09
0.96 ±0.04
0.98 ±0.06
1.03 ±0.04

1.08 ±0.04
1.01 ±0.05
0.98 ±0.04
1.02 ±0.05

1.03 ±0.03
0.98 ±0.04
0.96 ±0.07
1.00 ±0.03

P21cip
CHO
CHO+BCAA
CHO+LEU
PLC

1.03 ±0.03
1.03 ±0.10
0.94 ±0.03
1.04 ±0.03

> PRE
1.05 ±0.06
1.05 ±0.09
1.10 ±0.10
1.10 ±0.09

> PRE
1.08 ±0.10
1.04 ±0.08
1.12 ±0.09
1.10 ±0.07

> PRE
1.08 ±0.11
1.04 ±0.05
1.11 ±0.09
1.11 ±0.06

P27kip
CHO
CHO+BCAA
CHO+LEU
PLC

1.06 ±0.12
1.08 ±0.09
1.02 ±0.03
1.13 ±0.10

1.05 ±0.11
1.03 ±0.08
1.09 ±0.11
1.05 ±0.09

1.03 ±0.10
0.99 ±0.08
1.08 ±0.06
1.07 ±0.03

1.02 ±0.07
1.01 ±0.07
1.03 ±0.05
1.04 ±0.05

Variable

G

T

G×T

0.001 *
> CHO+LEU, PLC
> CHO+LEU, PLC

0.38

0.13

0.001 *

0.32

0.91

0.27

0.009 †

0.47

0.37

0.37

0.73

< CHO
< CHO
< CHO

Data are presented as means ±SD for the ratio of Ct values for β-actin and each target mRNA variable. G, T, and G×T represent the univariate main effects
for group, time, and group × time interaction, respectively, at a probability level of ≤ 0.05. The symbol * denotes a significant main effect for group. For
myostatin, CHO and CHO+BCAA were significant greater than CHO+LEU and PLC. For ActRIIB, CHO was significantly greater than CHO+BCAA,
CHO+LEU, and PLC, while CHO+LEU was greater than PLC. The symbol † denotes a significant main effect for time. PRE was significantly less than 30,
120, and 360 min post-exercise.

mRNA Expression for Markers of Myogenic
Inhibition
Upon further analysis with univariate ANOVA,
signifcant group main effects were observed for
myostatin (p = 0.001; effect size = 1.00) and
ActIIB (p = 0.001; effect size = 0.99). Post-hoc
analysis showed that for myostatin CHO and
CHO+BCAA were significantly greater than
CHO+LEU and PLC. For ActIIB, CHO was significantly greater than CHO+BCAA, CHO+LEU,
and PLC.
Analysis of the time main effects also produced significant differences between time points
for p21cip (p = 0.009; effect size = 0.829). Posthoc analysis showed that 30, 120, and 360 min
post-exercise were significantly greater than PRE
(Table 5).
DISCUSSION
The primary purpose of this study was to determine if the co-ingestion of carbohydrate with ei10	
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ther BCAA or L-leucine in conjunction with a
single bout of resistance exercise had any preferential effect to placebo or carbohydrate or placebo on serum IGF-1 and skeletal muscle mRNA
expression of markers involved in activiating and
inhibiting myogenic activation of satellite cells.
In general, we observed resistance exercise to
have no effect on serum IGF-1, but there was an
effect on the expression of several genes. However, we observed no preferential RE-induced
effects from the ingestion of any of the supplements for the variables assessed.
Since IGF-1 is known to be a humoral myogenic activator based on its binding and subsequent activation of its respective transmembrane
receptor, we were compelled to determine the
responsiveness of serum IGF-1 to resistance exercise and/or CHO and amino acid ingestion. In
the present study, the response in the supplement
groups for serum IGF-1 was not related to RE.
This is congruent with our previous work using
the same resistance exercise protocol, which also
revealed no exercise-induced effects on the hepatically-derived release of IGF-1 (Taylor et al.
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2012). An earlier study also demonstrated the
unresponsiveness of serum IGF-1 to a single bout
of resistance exercise (Kraemer et al. 1992).
We also suspected that insulin may also play
a role in myogenically-related gene expression
by virtue of the role that insulin receptor substrate 1 (IRS-1) autophosphorylation plays in increasing ERK 1/2 and Akt-mTOR signaling relative to transcriptional and translational mechanisms. Although not shown in the present study,
our previous study (Ferreira et al. 2014) demonstrated significant increases in serum insulin
compared to PLC that peaked at the 30 min postexercise sampling point for both CHO-containing
supplement groups. We observed the same response for the CHO+LEU group in the present
study. Furthermore, none of these three intervention groups differed in regards to insulin levels
(data not shown). Therefore, there were no preferential interactive effects from exercise and nutritional intervention on serum insulin or IGF-1.
As a result, since there were no RE-related effects in any of the supplement groups on the expression of any of our targeted genes, the impact
that either of these hormones played on the pretranslational activation of our selected genes appears to be negligible.
A single bout of heavy RE is sufficient to
induce a transient up-regulation of musclespecific gene expression (Wilborn et al. 2009;
Willoughby & Nelson, 2002). Following a single
bout of RE, the mRNA expression of the myogenic activators, Myo-D, myogenin, MRF-4, and
myf5 were up-regulated at 30, 120, and 360 min
post-exercise (Psilander et al. 2002; Wilborn et al.
2009; Willoughby & Nelson, 2002), and Cyclin
B1 was significantly up-regulated 24 hr post- exercise (Kim et al. 2005; Wilborn et al. 2009). In
older men, Myo-D, myogenin, and p27kip have
been shown to be unresponsive to a single bout
of RE when assessed one hr post-exercise (Hulmi
et al. 2007). In agreement with previous results,
in the present study we observed RE-induced increases in the mRNA expression of Cyclin B1 at
30 and 120 min post-exercise and Cyclin D1 at
120 and 360 min post-exercise. We also observed a strong trend towards significance in response to RE for MRF-4 based on p-value of
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0.07 and a corresponding effect size of 0.58,
which suggests this gene to be somewhat responsive to our RE intervention. Relatedly, in response to 45 min of treadmill running at 77% of
VO2max, MRF-4 was increased in human vastus
lateralis 4 hr post-exercise, while myogenin was
unaltered (Harber et al. 2009)
A single bout of RE has also been shown to
down-regulate the myogenic inhibitors, myostatin, and p27kip (Hulmi et al. 2008; Kim et al.
2005; Wilborn et al. 2009). Additionally, treadmill running has also been shown to result in a
decrease in myostatin mRNA expression at 240
min post-exercise (Harber et al. 2009). However,
in middle-aged men a single bout of RE has been
shown to increase p21cip 60 min post-exercise
(Hulmi et al. 2008). In older men, a single bout
of RE exercise has been shown to down-regulate
myostatin and ActIIB mRNA (Hulmi et al. 2007).
Herein, we demonstrate a responsiveness to resistance exercise, as p21cip mRNA was upregulated at 30, 120, and 360 min post-exercise.
Relative to the intake of nutrients, previous
investigations have demonstrated conflicting results regarding the immediate ingestion of amino
acids and/or carbohydrate after endurance- and
resistance-related exercise. For example, the ingestion of 8.6 g of BCAAs (7 g leucine) one hr
following RE resulted in a decreased myostatin
mRNA expression at 180 and 360 min postexercise. This occurred with concomitant increases in myogenin at 180 and 360 min postexercise and Myo-D at 360 min post-exercise
(Drummond et al. 2009). In middle-aged men, it
was demonstrated that 15 g of whey isolate
(~ 1.6 g of leucine) in conjunction with RE had
no differential effect from placebo relative to the
observed decreases in myostain mRNA expression at 60 min post-exercise (Hulmi et al. 2008).
In addition, p21cip was increased at 60 min postexercise compared to baseline for placebo but not
the whey protein group. Following 60 min of cycle ergometry at 72% of VO2max during periods
of either fasting or a meal containing 62 g of carbohydrate and approximately 9 g leucine, 5 g isoleucine, and 6 g valine, MRF-4 mRNA expression was increased at 120 and 360 min postexercise during the fasting condition only (Har-
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ber et al. 2010). In a study involving the ingestion of 10 g EAA (BCAA content equaling 3.5 g
leucine, 0.8 g isoleucine, 1.0 g valine), but with
no exercise intervention, myostatin mRNA was
decreased and Myo-D increased 180 min postingestion (Drummond et al. 2009).
In the present study, we have attempted to
delineate a possible preferential role that leucine
might play compared to carbohydrate and/or
BCAA in regards to the expression of genes involved in myogenic activity of satellite cells. Our
present results, along with a number of previous
studies, have provided compelling evidence that
various genes serving as markers of the myogenic activity of satellite cells are load-sensitive, irrespective of muscle contractions involved in
either resistance or endurance exercise. However,
in line with previous studies our observation substantiate the lack of congruence that exists regarding the effectiveness of amino acid ingestion
on pre-translational markers indicative of the
myogenic activity of satellite cells.
In the present study, the three experimental
groups received the equivalent amount of carbohydrate. The amino acid-containing groups both
received the equivalent amount of leucine, which
was provided at a relative dose of 60 mg/kg, and
based on the range in body mass (approximately
67-95 kg), constituted an approximate leucine
dose in the range of 4-6 g. This is unlike the previously-mentioned studies which provided absolute doses of amino acids and/or leucine ranging
anywhere between 2-9 g. Based on the differences in macronutrient intakes, particularly amino acids, attempting to confidently corroborate
our results with previous studies is challenging.
Relative to the intake of amino acids, with the
exception of cyclin D1, we have shown no preferential RE-induced effect from carbohydrate,
BCAA, or L-leucine intake on serum IGF-1 or
any of the gene targeted for analysis that are
known markers in either the activation or inhibition of satellite cell activity. In regard to cyclin
D1, in the absence of any carbohydrate and/or
amino acid-induced effect on any of the other
genes assessed, it is difficult to interpret the importance of this result.
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Even though the role of carbohydrate and/or
amino acids has not been conclusively demonstrated, the present study helps to solidify the understanding regarding the effectiveness of resistance exercise in regulating the pretranslational activity of markers of satellite cell
activity. Therefore, in light of the results presented herein, we conclude that the co-ingestion of
carbohydrate with either BCAA or L-leucine in
conjunction with RE has no preferential effect on
serum IGF-1 or pre-translational markers indicative of myogenesis.
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